Create issue ticket

23 Possible Causes for Coagulation Factor Disorder, Fibrin Degradation Products Increased, Lactate Dehydrogenase Increased

  • Disseminated Intravascular Coagulation

    Plasma exchange only improved lactate dehydrogenase levels. We clinically diagnosed this case as atypical HUS and started eculizumab treatment.[] coagulation factors.[] Fibrin degradation products (FDPs) are also increased and fibrinogen levels will decrease.[]

  • Pulmonary Embolism

    […] cell anemia, congenital coagulation disorders, chest trauma, certain congenital heart defects, and old age.[] D-dimers - fibrin D-dimer is a degradation product of cross-linked fibrin.[] In these conditions, D-dimer, an end-stage product of fibrin degradation by plasmin, is increased as a result of fibrinolysis, but it does not result from fibrinogenolysis[]

  • Pulmonary Infarction

    Coagulation disorders: Conditions such as deficiency of protein S or C and antithrombin III deficiency.[] D-dimers - fibrin D-dimer is a degradation product of cross-linked fibrin.[] Anticoagulation therapy should be administered to patients prior and after a major surgical procedure, patients with DVT or coagulation disorders should be appropriately treated[]

  • Acute Monocytic Leukemia

    慢性骨髄増殖性疾患 coagulation factor凝固因子 complete remission (CR)完全寛解 concentrated red cells濃厚赤血球 consolidation therapy地固め療法 cord blood stem cell transplantation (CBT)臍帯血移植 d dendritic[] […] marker細胞表面マーカー chronic graft versus host disease (chronic GVHD)慢性移植片対宿主病 chronic lymphocytic leukemia慢性リンパ性白血病 chronic myelocytic leukemia 慢性骨髄性白血病 chronic myeloproliferative disorders[]

  • Ebola Virus Disease

    […] that induces the development of coagulation irregularities seen in EBOV infections DIC is not a primary disorder but is a complication of an underlying disease, usually an[] Development of fibrin degradation products (D-dimers) showed rapid increases of 35-fold by day 5 and 45-fold by day 7 ( Figure 1 ).[] […] factors, particularly during the later stages of disease, the data presented here strongly implicate TF expression/release from EBOV-infected monocytes/macrophages as a key factor[]

  • Deep Vein Thrombosis

    […] syndrome associated with elevated D-dimers, lactate dehydrogenase, and liver transaminases in a population of patients with B-cell chronic lymphocytic leukemia receiving[] Blood tests showed inflammatory activity, a slight increase of D-dimer and Fibrin Degradation Product.[] Increased levels of D-dimers, fibrin degradation products (FDPs), or fibrin monomers in the plasma may reflect low-grade intravascular coagulation.[]

  • Preeclampsia

    lactate dehydrogenase (LDH) levels.[] Preeclampsia is an endothelial disorder resulting from poor placental perfusion, which releases a factor that injures the endothelium, causing activation of coagulation and[] The coagulation system is activated, possibly secondary to endothelial cell dysfunction, leading to platelet activation.[]

  • Hemothorax

    Available from: Introduction Hemophilia A is an X-linked autosomal recessive disorder of coagulation presenting with deficiency of Factor VIII.[] HFP contained elevated levels of fibrin-degradation products and tissue factor compared with control fresh frozen plasma samples.[] Hemophilia A Hemophilia A is a life-threatening hemorrhagic disorder caused by the development of an inhibitor against coagulation factor VIII (FVIII).[]

  • HELLP Syndrome

    Although a significant trend was apparent in increasing levels of lactate dehydrogenase, aspartate aminotransferase, and uric acid as HELLP syndrome worsened, there was considerable[] Coagulation studies, such as PT and aPTT and a peripheral blood smear, can be helpful to distinguish these disorders.[] The association between coagulation activation and pre-eclampsia has long been recognized and includes excessive platelet activation, increased fibrin degradation products[]

  • Thrombotic Thrombocytopenic Purpura

    The hematological changes in vitamin B12 deficiency present as megaloblastic anemia, increased lactate dehydrogenase, vasoconstriction, increased platelet aggregation, and[] Immune System Diseases Thrombophilia Rituximab Antineoplastic Agents, Immunological Antineoplastic Agents Immunologic Factors Physiological Effects of Drugs Antirheumatic[] In the laboratory examination; anemia, low platelet count; increased indirect bilirubin, lactate dehydrogenase (LDH) levels were found, and fever was 38.4 C.[]